We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

QIAGEN Launches First FDA-approved Companion Diagnostic Using FGFR Alterations to Help Guide the Treatment of Metastatic Urothelial Cancer

Product News   Apr 15, 2019

 
QIAGEN Launches First FDA-approved Companion Diagnostic Using FGFR Alterations to Help Guide the Treatment of Metastatic Urothelial Cancer

Image credit: QIAGEN

FURTHER INFORMATION
 
 
 

Related Product News

Qlucore Expands Into Precision Medicine and Diagnostics

Product News

Qlucore, a developer of bioinformatics software, is expanding into the area of precision medicine and precision diagnostics.

READ MORE

PAA to Showcase New Laboratory Automation Solutions at SLAS2020

Product News

Peak Analysis & Automation (PAA) will be showcasing its new KX-2™ collaborative robot and providing interactive tours of its S-CEL™ laboratory workcell at SLAS2020.

READ MORE

LabCorp to Accelerate Oncology Research with Thermo Fisher Scientific

Product News

LabCorp has announced that it will adopt Thermo Fisher Scientific’s Ion Torrent Genexus System and Oncomine Precision Assay for use in research and development of companion diagnostics.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE